trending Market Intelligence /marketintelligence/en/news-insights/trending/hMsymKwqiN3yKVLtvA9d7w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

FSD Pharma picks up 12.25% stake in cannabis cultivator Cannara Biotech

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


FSD Pharma picks up 12.25% stake in cannabis cultivator Cannara Biotech

FSD Pharma Inc. acquired about 12.25% stake in Canadian cannabis cultivator Cannara Biotech Inc.

Cannara Biotech was formed following the merger of the company with Dunbar Capital Corp. and 11038427 Canada Inc.

Canadian cannabis company FSD now owns 85,003,750 common shares of Cannara and may increase or decrease its ownership, subject to the terms of an escrow arrangement.

Cannara, which completed the acquisition of Dunbar on Dec. 31, 2018, said its common shares began trading on the Canadian Securities Exchange on Jan. 14 under the symbol LOVE.